GlobeNewswire Inc.Oct 11, 1:00 PM ET▲ Positive
Company demonstrated significant performance improvements in its updated CRC screening test with higher sensitivity rates across all advanced precancerous lesion subtypes. FDA approval achieved, commercial launch completed with Abbott partnership, and expansion into lung cancer screening with Breakthrough Device Designation indicate strong progress and market validation.